PharmaDrug appoints world-renowned chemist and neuroscientist Dr Steven Barker to its scientific advisory board for psychedelic pharmaceuticals
He will lead the R&D initiatives of N,N-Dimethyltryptamine (DMT) for mental health, neurological, and inflammatory disorders